Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNS disorders
Details for Australian Patent Application No. 2005215767 (hide)
International Classifications
Event Publications
14 September 2006 PCT application entered the National Phase
PCT publication WO2005/079773 Priority application(s): WO2005/079773
21 October 2010 Alteration of Name
The name of the applicant has been altered to Adamas Pharmaceuticals, Inc.
8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005215769-System and method for motion-controlled foot unit
2005215762-Improvements in or relating to the defeat of the copy protection of optical discs
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser